2018 in Review: Top Podcast Episodes on Tech Trends
The digital disdain for boundaries is a powerful change agent. Catch up on the top episodes from Beyond the Book in 2018 about tech trends.
2018 in Review: CCC’s Top Headlines on Digital Transformation, Copyright Law and Open Access
Notable topics from 2018 included digital transformation, info management in life sciences, Open Access and copyright legislation.
How Agile Are You? Why R&D Strategy, Structure & Decision Making Needs to Shift
As pharma companies look to improve their R&D productivity in the new year, some are shifting from a traditional mindset… Read more
What the World’s Largest IT Leadership Study Tells Us About the State of the Pharma Industry
The latest Harvey Nash/KPMG CIO Survey – the largest IT leadership study in the world – helps us gauge how pharma firms are adopting digital technologies.
Big Pharma Launches Digital Transformation Plans into Overdrive
Pharma industry leaders are realizing the impact of digital transformation efforts. But new research shows 3 in 4 are still in the early phases of digital development.
Join CCC at AWS re:Invent 2018
Together with our partner Alfresco, we will be at Quad Expo #330 from November 26-30 for one of the most important global cloud computing events of the year.
AI Usage Growing Among Life Sciences Professionals – But Challenges Remain
From entertainment to healthcare, ecommerce to finance – it’s undeniable that the way we do business changes when artificial intelligence… Read more
Essential Resources for Life Sciences Organizations Undergoing Digital Transformation
For life sciences organizations to undergo successful digital transformation, they need tools that facilitate fluid access to relevant data.
How to Achieve Digital Dexterity: 4 Elements of Focus
Most large companies are not known for being nimble and agile. So how can these organizations develop the dexterity to compete in today’s digital age?
Technology a Stumbling Block for Pharma Firms in their Digital Transformation Journey
New research, conducted in Q4 2017 by TayganPoint Consulting Group and PharmaVoice, reveals that more than one in four life sciences companies expect large-scale transformation in the next three years.